Literature DB >> 9343251

An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence.

S Dethlefs1, M Brahic, E L Larsson-Sciard.   

Abstract

In genetically susceptible strains of mice, the DA strain of Theiler's virus, a picornavirus, causes a persistent infection of the white matter of the spinal cord associated with chronic demyelination. In resistant strains, on the other hand, the infection is cleared within 1 to 2 weeks. In this article, we show that Theiler's virus induces a rapid and abundant cytotoxic T lymphocyte (CTL) response in resistant C57BL/6 mice, while the response remains low throughout infection in susceptible SJL/J mice. This difference can be referred to a higher number of virus-specific CTL precursors in C57BL/6 mice. These observations indicate that the efficient induction of virus-specific CTL precursors is critical for avoiding the establishment of a persistent picornaviral infection.

Entities:  

Mesh:

Year:  1997        PMID: 9343251      PMCID: PMC192357     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.

Authors:  R S Fujinami; A Rosenthal; P W Lampert; A Zurbriggen; M Yamada
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus.

Authors:  C V Paya; A K Patick; P J Leibson; M Rodriguez
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

4.  Theiler's virus infection induces a specific cytotoxic T lymphocyte response.

Authors:  C Pena Rossi; A McAllister; L Fiette; M Brahic
Journal:  Cell Immunol       Date:  1991-12       Impact factor: 4.868

5.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Clonal specificity of concanavalin A-induced cytotoxic T lymphocytes.

Authors:  E L Larsson; A Beretta; M Ermonval
Journal:  Eur J Immunol       Date:  1985-04       Impact factor: 5.532

7.  Role of T cell receptor V beta genes in Theiler's virus-induced demyelination of mice.

Authors:  M Rodriguez; A K Patick; L R Pease; C S David
Journal:  J Immunol       Date:  1992-02-01       Impact factor: 5.422

8.  Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity.

Authors:  R J Clatch; R W Melvold; S D Miller; H L Lipton
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

9.  Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus.

Authors:  M D Lindsley; M Rodriguez
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

10.  Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.

Authors:  M Rodriguez; J Leibowitz; C S David
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  27 in total

1.  CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.

Authors:  K L Neville; M C Dal Canto; J A Bluestone; S D Miller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Preferential induction of protective T cell responses to Theiler's virus in resistant (C57BL/6 x SJL)F1 mice.

Authors:  Young-Hee Jin; Hyun Seok Kang; Mani Mohindru; Byung S Kim
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus.

Authors:  A Azoulay-Cayla; S Dethlefs; B Pérarnau; E L Larsson-Sciard; F A Lemonnier; M Brahic; J F Bureau
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Theiler's virus infection of perforin-deficient mice.

Authors:  C P Rossi; A McAllister; M Tanguy; D Kägi; M Brahic
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages.

Authors:  M L Linn; L Mateo; J Gardner; A Suhrbier
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus.

Authors:  M Trottier; P Kallio; W Wang; H L Lipton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection.

Authors:  Eric J Buenz; Brian M Sauer; Reghann G Lafrance-Corey; Chandra Deb; Aleksandar Denic; Christopher L German; Charles L Howe
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system.

Authors:  N Jarousse; E G Viktorova; E V Pilipenko; V I Agol; M Brahic
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 9.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Restraint stress fails to render C57BL/6 mice susceptible to Theiler's virus-induced demyelination.

Authors:  Andrew J Steelman; Eric Alford; Colin R Young; Thomas H Welsh; Mary W Meagher; C Jane R Welsh
Journal:  Neuroimmunomodulation       Date:  2009-11-17       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.